Intra-Cellular Therapies Inc (ITCI)
131.70
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
131.70
0.00 (0.00%)
Pre-Market: 20:00
Intra-Cellular Therapies Total Liabilities (Quarterly): 218.45M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 108.61B |
| Moderna Inc | 3.241B |
| Eli Lilly and Co | 64.44B |
| AbbVie Inc | 131.80B |
| Sage Therapeutics Inc | 82.13M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.367B |
| Shareholders Equity (Quarterly) | 1.148B |
| Current Ratio | 6.356 |